RAPPORT THERAPEUTICS, INC.
Last · —$28.33-0.66 (-2.28%)live · yahoo · 0s ago
Market cap$1.36B—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $20.0M |
|---|---|
| Operating income | $-85.0M |
| Net income | $-76.5M |
| Free cash flow | $-54.7M |
| Operating margin | -425.1% |
| Net margin | -382.4% |
| Return on equity | -18.1% |
| Period | 2026 |
Loading chart…
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.23
Est. revenue
0
Press & signals
- GlobeNewswire
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update